SCHEMBL23906346

SCHEMBL23906346

CC(C)c1c(N2CCCC2)nc2cc3[nH]ncc3cc2c1-c1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.43
GRIA1 P42261 4/20 0.38
CYP2C9 P11712 2/20 0.38
CACNG2 Q9Y698 1/20 0.38
NPY5R Q15761 1/20 0.38
ROCK2 O75116 5/20 0.37
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
ROCK1 Q13464 4/20 0.36
PKN2 Q16513 3/20 0.36
TGFBR1 P36897 1/20 0.36
PKN1 Q16512 1/20 0.36
TLR9 Q9NR96 1/20 0.36
TLR8 Q9NR97 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30252012 0.86 SCN9A (0.39) NAMPTGRIA1CYP2C9ROCK2CYP1A2
SCHEMBL23884427 0.86 SCN9A (0.39) NAMPTGRIA1CYP2C9ROCK2CYP1A2
SCHEMBL30251635 0.84 NAMPT (0.36) NAMPTGRIA1ROCK2CYP3A4TGFBR1
SCHEMBL23884659 0.84 NAMPT (0.36) NAMPTGRIA1ROCK2CYP3A4TGFBR1
SCHEMBL30251682 0.83 NOTUM (0.40) NAMPTGRIA1CYP1A2
SCHEMBL30251699 0.83 NOTUM (0.40) NAMPTGRIA1CYP1A2
SCHEMBL23884643 0.83 NOTUM (0.40) NAMPTGRIA1CYP1A2
SCHEMBL23884724 0.83 NOTUM (0.40) NAMPTGRIA1CYP1A2
SCHEMBL23906194 0.83 NOTUM (0.40) NAMPTGRIA1CYP1A2
SCHEMBL23884795 0.82 NAMPT (0.37) NAMPTGRIA1ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021203025-A1 1 H-PYRAZOLO[4,3-G]ISOQUINOLINE AND 1 H-PYRAZOLO[4,3-G]QUINOLINE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD) VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-10-07 WO disclosed